RSL
ReShape Lifescie
Stock
Stock
ISIN: US76090R4083
Ticker: RSLS
US76090R4083
RSLS
Price
Price
CHART BY
Frequently asked questions
What is ReShape Lifescie's market capitalization?
The market capitalization of ReShape Lifescie is $6.51M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for ReShape Lifescie?
ReShape Lifescie's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$210.70. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for ReShape Lifescie's stock?
Currently, 1 analysts cover ReShape Lifescie's stock, with a consensus target price of $1,450.00. Analyst ratings provide insights into the stock's expected performance.
What is ReShape Lifescie's revenue over the trailing twelve months?
Over the trailing twelve months, ReShape Lifescie reported a revenue of $7.18M.
What is the EBITDA for ReShape Lifescie?
ReShape Lifescie's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$6.28M. EBITDA measures the company's overall financial performance.
What is the free cash flow of ReShape Lifescie?
ReShape Lifescie has a free cash flow of -$4.57M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does ReShape Lifescie have, and what sector and industry does it belong to?
ReShape Lifescie employs approximately 18 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of ReShape Lifescie's shares?
The free float of ReShape Lifescie is 2.19M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $6.51M
- EPS (TTM)
- -$210.70
- Free Float
- 2.19M
- Revenue (TTM)
- $7.18M
- EBITDA (TTM)
- -$6.28M
- Free Cashflow (TTM)
- -$4.57M
Pricing
- 52W span
- $2.24$302.50
Analyst Ratings
The price target is $1,450.00 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, the Obalon Balloon System, and the Diabetes Bloc-Stim Neuromodulation device. The firm sells the Lap-Band worldwide and is managed in the following geographical regions: United States, Australia, Europe, and the Rest of World. The company was founded in December 2002 and is headquartered in Irvine, CA.
- Employees
- 18
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US76090R4083
- Primary Ticker
- RSLS
Fundamentals & EOD data from FactSet